Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
26 09 2019
Historique:
pubmed: 30 8 2019
medline: 23 6 2020
entrez: 30 8 2019
Statut: ppublish

Résumé

Chemical control of cullin neddylation is attracting increased attention based largely on the successes of the NEDD8-activating enzyme (E1) inhibitor pevonedistat. Recently reported chemical probes enable selective and time-dependent inhibition of downstream members of the neddylation trienzymatic cascade including the co-E3, DCN1. In this work, we report the optimization of a novel class of small molecule inhibitors of the DCN1-UBE2M interaction. Rational X-ray co-structure enabled optimization afforded a 25-fold improvement in potency relative to the initial screening hit. The potency gains are largely attributed to additional hydrophobic interactions mimicking the N-terminal acetyl group that drives binding of UBE2M to DCN1. The compounds inhibit the protein-protein interaction, block NEDD8 transfer in biochemical assays, engage DCN1 in cells, and selectively reduce the steady-state neddylation of Cul1 and Cul3 in two squamous carcinoma cell lines harboring DCN1 amplification.

Identifiants

pubmed: 31465221
doi: 10.1021/acs.jmedchem.9b00410
pmc: PMC7228038
mid: NIHMS1586503
doi:

Substances chimiques

Amides 0
CUL3 protein, human 0
Cullin 1 0
Cullin Proteins 0
Cyclopentanes 0
DCUN1D1 protein, human 0
Intracellular Signaling Peptides and Proteins 0
NEDD8 Protein 0
NEDD8 protein, human 0
Pyrazoles 0
Pyridones 0
Pyrimidines 0
Reactive Oxygen Species 0
Ubiquitin-Conjugating Enzymes EC 2.3.2.23
UBE2M protein, human EC 6.3.2.-
pevonedistat S3AZD8D215
Glycine TE7660XO1C

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

8429-8442

Subventions

Organisme : NCI NIH HHS
ID : R01 CA247365
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NIGMS NIH HHS
ID : F32 GM113310
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIGMS NIH HHS
ID : R37 GM069530
Pays : United States

Références

Clin Cancer Res. 2003 Jun;9(6):2300-6
pubmed: 12796399
J Med Chem. 2019 Mar 14;62(5):2772-2797
pubmed: 30803229
Cell Res. 2016 Apr;26(4):484-98
pubmed: 27002218
Cell Div. 2016 Jun 10;11:8
pubmed: 27293474
Nat Commun. 2016 Oct 24;7:13166
pubmed: 27774986
Drug Discov Today. 2009 Nov;14(21-22):1011-20
pubmed: 19729075
Cancer Chemother Pharmacol. 2018 May;81(5):797-808
pubmed: 29450620
J Cell Sci. 2016 Apr 1;129(7):1441-54
pubmed: 26906416
Ann Surg Oncol. 2004 May;11(5):530-4
pubmed: 15123463
J Biol Chem. 2008 Nov 28;283(48):33211-20
pubmed: 18826954
Nat Chem Biol. 2017 Aug;13(8):850-857
pubmed: 28581483
Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4283-4291
pubmed: 29077169
Org Lett. 2016 Feb 19;18(4):696-9
pubmed: 26859161
J Med Chem. 2018 Mar 8;61(5):1934-1950
pubmed: 29438612
Clin Cancer Res. 2013 Oct 15;19(20):5549-51
pubmed: 24004673
J Med Chem. 2018 Apr 12;61(7):2694-2706
pubmed: 29547693
PLoS One. 2014 May 29;9(5):e98293
pubmed: 24874471
Science. 2011 Nov 4;334(6056):674-8
pubmed: 21940857
J Biol Chem. 2016 Mar 18;291(12):6200-17
pubmed: 26792857
Dev Biol. 2018 Jan 15;433(2):210-217
pubmed: 29291974
Exp Ther Med. 2018 Aug;16(2):1000-1008
pubmed: 30116351
Cancer Res. 2006 Oct 1;66(19):9437-44
pubmed: 17018598
Medicina (Kaunas). 2015;51(1):1-9
pubmed: 25744769
Cell Signal. 2018 Apr;44:92-102
pubmed: 29331584
Trends Biochem Sci. 2018 Feb;43(2):95-107
pubmed: 29249570
Cell. 2014 Jun 19;157(7):1671-84
pubmed: 24949976
Science. 2013 Jul 5;341(6141):84-7
pubmed: 23828940
Curr Opin Struct Biol. 2011 Apr;21(2):257-64
pubmed: 21288713
Nat Commun. 2017 Oct 27;8(1):1150
pubmed: 29074978
Nature. 2005 Jun 30;435(7046):1257-61
pubmed: 15988528
Ann Thorac Surg. 2004 Nov;78(5):1734-41
pubmed: 15511464
Clin Cancer Res. 2008 Nov 1;14(21):6780-9
pubmed: 18980971
Curr Opin Struct Biol. 2010 Dec;20(6):714-21
pubmed: 20880695
Trends Cell Biol. 2014 Jul;24(7):389-99
pubmed: 24630736
J Clin Invest. 2014 Jan;124(1):6-12
pubmed: 24382383
Biochem J. 2015 May 1;467(3):365-86
pubmed: 25886174
Annu Rev Biochem. 2017 Jun 20;86:129-157
pubmed: 28375744
J Med Chem. 2018 Apr 12;61(7):2680-2693
pubmed: 29547696
Structure. 2013 Jan 8;21(1):42-53
pubmed: 23201271
Mol Cell. 2013 May 23;50(4):540-51
pubmed: 23603116
Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20
pubmed: 15688063

Auteurs

Ho Shin Kim (HS)

Department of Pharmaceutical Sciences , University of Kentucky , Lexington , Kentucky 40508 , United States.

Jared T Hammill (JT)

Department of Pharmaceutical Sciences , University of Kentucky , Lexington , Kentucky 40508 , United States.

Daniel C Scott (DC)

Department of Structural Biology , St. Jude Children's Research Hospital , Memphis , Tennessee 38105 , United States.

Yizhe Chen (Y)

Department of Pharmaceutical Sciences , University of Kentucky , Lexington , Kentucky 40508 , United States.

Jaeki Min (J)

Department of Chemical Biology and Therapeutics , St. Jude Children's Research Hospital , Memphis , Tennessee 38105 , United States.

Jonah Rector (J)

Department of Pharmaceutical Sciences , University of Kentucky , Lexington , Kentucky 40508 , United States.

Bhuvanesh Singh (B)

Department of Surgery, Laboratory of Epithelial Cancer Biology , Memorial Sloan Kettering Cancer Center , New York New York 10065 , United States.

Brenda A Schulman (BA)

Department of Structural Biology , St. Jude Children's Research Hospital , Memphis , Tennessee 38105 , United States.
Department of Molecular Machines and Signaling , Max Planck Institute of Biochemistry , Martinsried 82152 , Germany.

R Kiplin Guy (RK)

Department of Pharmaceutical Sciences , University of Kentucky , Lexington , Kentucky 40508 , United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH